Lenalidomide and Chronic Lymphocytic Leukemia

Lenalidomide is an oral immunomodulatory drug used in multiple myeloma and myelodysplastic syndrome and most recently it has shown to be effective in the treatment of various lymphoproliferative disorders such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma. The mechanism of action of...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Rodríguez, Ana Pilar, Payer, Angel R., Acebes-Huerta, Andrea, Huergo-Zapico, Leticia, Villa-Alvarez, Monica, Gonzalez-García, Esther, Gonzalez, Segundo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791640/
https://www.ncbi.nlm.nih.gov/pubmed/24163824
http://dx.doi.org/10.1155/2013/932010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791640/
https://www.ncbi.nlm.nih.gov/pubmed/24163824
http://dx.doi.org/10.1155/2013/932010

Ejemplares similares